Joseph S Dillon

5PUBLICATIONS
18CO-AUTHORS
Predictive and prognostic markersNutritional epidemiologyGene and molecular therapyRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 27, 2026
A Novel Radiomics-Integrated Panel for Preoperative Stratification of Pancreatic Neuroendocrine Tumors (PNETs).

|May 22, 2025
Risk Factors Associated with Gastroenteropancreatic and Lung Neuroendocrine Tumors: A Nested Case-Control Study from the All of Us Research Program.

Tao Xu, Joseph S Dillon, Dawn E Quelle

|Mar 09, 2021
High-Specific-Activity-131I-MIBG versus 177Lu-DOTATATE Targeted Radionuclide Therapy for Metastatic Pheochromocytoma and Paraganglioma.

Abhishek Jha, David Taïeb, Jorge A Carrasquillo

|Jan 28, 2021
High-specific-activity 131iodine-metaiodobenzylguanidine for therapy of unresectable pheochromocytoma and paraganglioma.

Joseph S Dillon, David Bushnell, Douglas E Laux

|Mar 09, 2020
Time to Sustained Improvement in Bowel Movement Frequency with Telotristat Ethyl: Analyses of Phase III Studies in Carcinoid Syndrome.

Joseph S Dillon, Matthew H Kulke, Dieter Hörsch

Pageof 1

Frequent Collaborators

2 joint publications

Michael O'Rorke

1 joint publications

Abdallah Attia

1 joint publications

Nicholas Skill

1 joint publications

Abhishek Jha